Petaling Jaya, Malaysia – Royal Philips (NYSE: PHG, AEX: PHIA) Did you know that it only takes five minutes a day, once a month and a total of one hour a year to save your life? Breast cancer is one the most frequently detected cancers and is the second leading cause of death among women worldwide with an estimated 1.6 million new cases detected each year. In Malaysia, it is the most common cancer and the leading cause of cancer deaths amongst women1. With early detection, thousands of lives can be saved each year. Many countries have shown a five-year survival rate of over 90% when the breast cancer is detected before it spreads to the lymph nodes2. Philips believes in adopting an integrated approach with dedicated solutions to support breast cancer care across the health continuum.
There is a need for increasing awareness on preventive screening for breast cancer amongst Malaysians,” said Mr Muhammad Ali Jaleel, Country Manager of Philips Malaysia. “While digital mammography has proven to be a powerful diagnostic tool for early detection of breast cancer, it is also important to practise breast self-examination at home. It only takes a total of one hour in a year to save your life or that of a loved one.
Muhammad Ali Jaleel
Country Manager for Philips Malaysia
In conjunction with Breast Cancer Awareness month, Philips Malaysia aims to create awareness on how Malaysians can detect the signs of breast cancer.
Here are seven common signs of breast cancers for Malaysians to be aware of. You will notice an unusual difference in size or shape, unusual rash or colour on skin, change in nipple position, turning in of the nipple, dimpling or puckering of the skin, unusual discharge from the nipple and unusual lump on any part of the breast.
It is recommended to conduct the examination once a month or during pregnancy. Philips’ healthcare solutions for breast cancer care extend across the health continuum, with an integrated ecosystem of innovative healthcare technology for screening, diagnosis, treatment and follow-ups. The portfolio includes mammography, ultrasound and imaging machines; advanced information systems that aid in diagnosis, remote consultation and evaluation of treatment outcomes; as well as radiation treatment machines. To learn more about Philips Breast Cancer Solutions, please visit http://www.usa.philips.com/healthcare/resources/landing/breast-cancer-solutions.
1 Barriers to breast self-examination practice among Malaysian female students: a cross sectional study, 2015, http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642456/ 2 Source: Philips Healthcare, 2016 - http://www.healthcare.philips.com/main/clinicalspecialities/WomensHealthCare/imaging/mammography/index.wpd
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2018 sales of EUR 18.1 billion and employs approximately 78,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
Senior Manager
Brand and Communications
Philips ASEAN Pacific